NextGen 2010

Leveraging new drug delivery systems, exploiting the potential of nanotechnology, adopting novel formulation and combination strategies are just some of the routes to improved generic product development. But just how aware are you of the regulatory and commercial implications of adopting these approaches to drive super generics?

Attend NextGen 2010 in Mumbai, India, and gain in-depth answers to these complex questions. This programme has been researched in great depth with representatives of the local and international pharmaceutical industry to bring you two intensive days of insights, analyses, benchmarking and facilitated networking.

Just some of the highlights of the conference include:

Case Study Presentations – from Ranbaxy, Dr. Reddy's Laboratories, Sun Pharmaceuticals, GlaxoSmithKline, Teva, Merck, Reliance Life Sciences, amongst others…
In-Depth Analysis - of the technical challenges, marketing opportunities, partnership options, and pricing and promotion strategies
Regulatory Guidance - on both the evolving domestic scenario and the ever stringent international requirements